Please read more about TheraVida, a clinical stage specialty pharmaceutical company focused on the development of THVD-102 for the treatment of primary focal hyperhidrosis. THVD-102’s systemic approach gives it the unique potential to address patients suffering from both primary focal and secondary generalized hyperhidrosis.

Celebrating our Newest Clients
We at Rankin McKenzie are proud and excited to have recently added the following local companies to our diverse clientele: Casey Creative– a creative company